Inactive

NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: NCATS Robotic Consumable Plates – Transwell (Corning) brand (i) This is a combined synopsis/solicitation for commercial items prepared in accord... NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: NCATS Robotic Consumable Plates – Transwell (Corning) brand (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95020Q00077 and the solicitation is issued as a request for quotation. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisitions – NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Corning Life Sciences, 836 North Street, Building 300, Sutie 3401, Tewksbury, MA 01876, for Transwell-brand well plates. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2020-05 dated March 30, 2020. (iv) The associated NAICS code is 326199 and the small business size standard is 750 employees. No set-aside restriction applies. (v) This acquisition consists of the following Transwell-brand well plates: 1. 3391 – TW, HTS, 96WL, W/PC MEMBRANE, 2 LI, 5/CS, quantity 50 cases 2. 3382 – TW, 96WL, HTS, receiver microplate, 10/CS, quantity 10 cases 3. 3377 – 96-WELL HTS EMPTY TRANSWELL PLATES, 8/CS, quantity 60 cases (vi)Delivery shall be in four quarterly shipments according to the following schedule: Delivery 1: 3391 – 12 cases 3382 – 5 cases 3377 – 15 cases Delivery 2: 3391 – 12 cases 3382 – 0 cases 3377 – 15 cases Delivery 3: 3391 – 13 cases 3382 – 5 cases 3377 – 15 cases Delivery 4: 3391 – 13 cases 3382 – 0 cases 3377 – 15 cases (vii) Delivery shall be to: The National Center for Advancing Translational Sciences (NCATS) 9800 Medical Center Drive Rockville, MD 20850 Delivery of the first shipment shall be within four weeks after receipt of order. Shipping must be included in the quote. Offeror to specify FOB terms; however, offers must state shipping costs if not included in price. (viii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition. CONTENTS OF THE QUOTE (to be provided by the Offeror, or presented on Offeror’s standard quotation form): 1. Name of Company. 2. Street Address, City, State, Zip code. 3. Name of Person, telephone number, and e-mail address of person authorized to provide quote. 4. DUNS number. 5. Period of Performance OR Delivery Date After Receipt of Order. 6. Contract number (and title) if quoting based on a contract vehicle other than open market (such as GSA Federal Supply Schedules; other Government agency (OGA) contracts, Government-wide Acquisition Contracts (GWACs); or National Institute of Health (NIH) Blanket Purchase Agreements (BPA)). 7. Technical description of the product or service offered, in sufficient detail to evaluate compliance with the requirements of the Product Description above. Provide product or catalog number(s); product or service description, list price, unit price, unit discounts, total price, any shipping and handling costs, country of origin, etc. 8. Shipping costs and terms (f.o.b. and other terms as applicable). 9. Payment discount terms. 10. Proof that offeror is manufacturer or authorized seller/reseller of brand-name items. Gray market supplies are not acceptable. 11. Any other information or factors that may be considered in the award decision. (ix) Evaluation. Offers will be evaluated for technical criteria, price, and past performance. Technical criteria consist of matching the line items identified above. Technical and past performance, when combined, are significantly more important than price. (x) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Items, with offers. (xi) The FAR clause at 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition. The following FAR provisions or clauses are incorporated by reference: 52.204-7, System for Award Management (Oct 2018) 52.204-13, System for Award Management Maintenance (Oct 2018) 52.204-16, Commercial and Entity Code Reporting (Jul 2016) 52.204-18, Commercial and Entity Code Maintenance (Jul 2016) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015). 52.212-4(g), Invoice, is supplemented by the NIH Invoice and Payment Instructions (2/2014). (xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders–Commercial Items, applies to this acquisition. (xv) This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. A determination by the Government whether to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered to determine whether to proceed on a non-competitive basis as indicated above, or to conduct a competitive procurement. If the Government opts to use a competitive procurement, offers will be evaluated using a comparative evaluation approach in accordance with FAR 13.106-2(b)(3). In that case, award will be made to the responsible offeror whose response meets the solicitation’s requirements and, as a whole, will be most advantageous to the Government, price and other factors considered. The comparative evaluation will include: Technical Capability of the item(s)/service(s) to meet the Government requirement, Price, Terms and Conditions, and Past Performance. Responses may exceed capability or performance characteristics of the solicitation’s requirements. The Government reserves the right, but is not required, to award to a response that exceeds capability or performance characteristics of the solicitation’s requirements if it provides a benefit to the Government. Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. (xii) In addition, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must be received by 11:00 a.m. Eastern Time, Monday, April 13, 2020, and reference solicitation number 75N95020Q00077. Responses must be submitted by email to Stuart Kern, Contract Specialist, stuart.kern@nih.gov, 301-402-3334.